GJB2 and neoplasm: In agreement, we observed an increase in primary tumour incidence and tumour multiplicity when Cx26 was knocked down prior to DMBA treatments suggesting that expression of Cx26 acts in the context of a tumour suppressor and protects the mammary gland to primary mammary tumour onset.